Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach.
Ghisoni E, Morotti M, Sarivalasis A, Grimm AJ, Kandalaft L, Laniti DD, Coukos G.
Nat Rev Clin Oncol. 2024 Nov;21(11):801-817. doi: 10.1038/s41571-024-00937-4. Epub 2024 Sep 4.
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
Fang H, Wang SA, Hu S, Konoplev SN, Mo H, Liu W, Zuo Z, Xu J, Jorgensen JL, Yin CC, El Hussein S, Jelloul FZ, Tang Z, Medeiros LJ, Wang W.
Cytometry B Clin Cytom. 2022 Jul;102(4):283-291. doi: 10.1002/cyto.b.22085. Epub 2022 Jun 18.
Immunophenotype-guided interpretable radiomics model for predicting neoadjuvant anti-PD-1 response in stage III-IV d-MMR/MSI-H colorectal cancer.
Zhang Y, Zhang X, Zhong X, Huang L, Jiang W, Zhang C, Liu L, You R, Li Y, Yi X, Liu Z, Chen X, Li Z.
J Immunother Cancer. 2025 Aug 4;13(8):e011569. doi: 10.1136/jitc-2025-011569.
Immunophenotype investigation in feline intestinal non-B-cell lymphoma.
Wolfesberger B, Gradner G, Rütgen BC, Hittmair KM, Walter I, Donovan TA, Kleiter M, Krischak A, Burgener IA, Fuchs-Baumgartinger A.
J Comp Pathol. 2024 Jul;212:20-26. doi: 10.1016/j.jcpa.2024.05.004. Epub 2024 Jun 28.
Intestinal-Type Adenocarcinoma: Classification, Immunophenotype, Molecular Features and Differential Diagnosis.
Leivo I.
Head Neck Pathol. 2017 Sep;11(3):295-300. doi: 10.1007/s12105-017-0800-7. Epub 2017 Mar 20.
Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms.
Liang F, Liang X, Pan L, Jin Q, Deng J, Hong M, Wei W, Hao Z, Ren H, Wang H, Chen X.
Clin Exp Med. 2024 May 21;24(1):106. doi: 10.1007/s10238-024-01363-7.
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma.
Li R, Wen X, Lv RX, Ren XY, Cheng BL, Wang YK, Chen RZ, Hu W, Tang XR.
Cell Oncol (Dordr). 2024 Aug;47(4):1129-1148. doi: 10.1007/s13402-024-00917-x. Epub 2024 Feb 5.
Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.
Escribano L, Díaz Agustín Beatriz, Bravo P, Navalón R, Almeida J, Orfao A.
Leuk Lymphoma. 1999 Oct;35(3-4):227-35. doi: 10.3109/10428199909145725.
Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML.
Tiso F, Koorenhof-Scheele TN, Huys E, Martens JHA, de Graaf AO, van der Reijden BA, Langemeijer SMC, Preijers FWMB, Kroeze LI, Jansen JH.
Ann Hematol. 2022 Mar;101(3):571-579. doi: 10.1007/s00277-021-04747-x. Epub 2022 Jan 13.
Immunophenotype of pediatric-onset mastocytosis does not correlate with clinical course.
Greenberger S, Landov H, Confino Y, Vaknine H, Avivi C, Baum S, Barzilai A.
Pediatr Dermatol. 2019 Jul;36(4):477-481. doi: 10.1111/pde.13850. Epub 2019 May 23.
